Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Side Effects of Transplant Immunosuppressive Therapy in Post Renal Transplant Recipients, Mazandaran, Northern Iran

Abazar Akbarzadeh Pasha 1 , Shayan Alijanpour 2 , * , Soraya Khafri 3 , Hoshmand Basim 4 and Mehran Afshang 5
Authors Information
1 Department of Urology, Babol University of Medical Sciences, Babol, Iran
2 Emergency Medical Service Center, Babol University of Medical Sciences, Babol, Iran
3 Department of Social Medicine, Babol University of Medical Sciences, Babol, Iran
4 Student Research Committee, Babol University of Medical Sciences, Babol, Iran
5 Babol University of Medical Sciences, Babol, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: April 2017, 19 (4); e6560
  • Published Online: April 15, 2017
  • Article Type: Research Article
  • Received: April 27, 2016
  • Accepted: April 22, 2017
  • DOI: 10.5812/zjrms.6560

To Cite: Akbarzadeh Pasha A, Alijanpour S, Khafri S, Basim H, Afshang M. Side Effects of Transplant Immunosuppressive Therapy in Post Renal Transplant Recipients, Mazandaran, Northern Iran, Zahedan J Res Med Sci. 2017 ; 19(4):e6560. doi: 10.5812/zjrms.6560.

Abstract
Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Akbarzadeh Pasha A, Sorkhi H, Razzaghi E, Oliaei F, Gholizadeh Pasha AR, Alizadeh Navaei R, et al. Outcome of 200 kidney transplantation in kidney transplant center of Shahid Beheshti hospital in Babol (Iran) [In persian]. J Babol Univ Med Sci. 2012; 14(2): 82-8
  • 2. Davies NM, Grinyo J, Heading R, Maes B, Meier-Kriesche HU, Oellerich M. Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant. 2007; 22(9): 2440-8[DOI][PubMed]
  • 3. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, T. Bustami R , Dyke DB. Immunosuppression: practice and trends. Am J Transplant. 2004; 4 Suppl 9: 38-53[DOI][PubMed]
  • 4. Hódi Z, Szenohradszky P, Marofka F, Szederkényi E. Gastrointestinal side effects of mycophenolate mofetil compared to mycophenolic acid in renal transplant patients. Z Gastroenterol. 2006; 44(5): 43-4[DOI]
  • 5. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet. 2000; 356(9225): 194-202[DOI][PubMed]
  • 6. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation. 1997; 63(7): 977-83[DOI][PubMed]
  • 7. Neumayer HH, Farber L, Haller P, Kohnen R, Maibucher A, Schuster A, et al. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant. 1996; 11(1): 165-72[DOI][PubMed]
  • 8. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med. 1998; 338(3): 161-5[DOI][PubMed]
  • 9. Boots JM, Christiaans MH, van Hooff JP. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs. 2004; 64(18): 2047-73[DOI][PubMed]
  • 10. Lo A, Alloway RR. Strategies to reduce toxicities and improve outcomes in renal transplant recipients. Pharmacotherapy. 2002; 22(3): 316-28[DOI][PubMed]
  • 11. Gentil MA, Lopez M, Gonzalez-Roncero F, Cantarell C, Marco J. Cost of renal transplant maintenance immunosuppression: effect of control of vascular risk factors. Transplant Proc. 2005; 37(3): 1464-5[DOI][PubMed]
  • 12. Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant. 2003; 17(3): 200-5[DOI][PubMed]
  • 13. Knoll GA, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol. 2003; 14(9): 2381-6[DOI][PubMed]
  • 14. Azmandiyan J, Sohravardi SM, Fazeli F, Etminan A, Sarveram A, Afzal F. The efficacy of amlodipine and diltiazem in cyclosporine dose adjustment with respect to trough and 2-hour concentrations in kidney transplant patients [In Persian]. J Kerman Univ Med Sci. 2009; 16(3): 197-205
  • 15. Radwan-Oczko M, Boratynska M, Klinger M, Zietek M. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A. Ann Transplant. 2003; 8(4): 57-62[PubMed]
  • 16. Hassell TM. Evidence for production of an inactive collagenase by fibroblasts from phenytoin-enlarged human gingivae. J Oral Pathol. 1982; 11(4): 310-7[DOI][PubMed]
  • 17. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol. 1987; 14(10): 610-3[DOI][PubMed]
  • 18. Seymour RA, Thomason JM, Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med. 1997; 26(7): 297-304
  • 19. Al-Mohaya MA, Darwazeh AM, Bin-Salih S, Al-Khudair W. Oral lesions in Saudi renal transplant patients. Saudi J Kidney Dis Transpl. 2009; 20(1): 20-9[PubMed]
  • 20. Pourmand MR, Keshtvarz M, Soltan Dallal MM, Talebi M, Bakhtiari R. Urinary tract infection in renal transplant patients in Sina University hospital [In Persian]. Tehran J Univ Med Sci . 2014; 71(2): 114-21
  • 21. Soleimani AR, Mianesaz E, Tamadon MR, Mousavi SGA. Evaluation of the relationship between diabetes mellitus and kidney transplantation [In Persian]. Feyz J Kashan Univ Med Sci. 2008; 12(3): 63-7
  • 22. Gunnarsson R, Arner P, Lundgren G, Magnusson G, Ostman J, Groth CG. Diabetes mellitus--a more-common-than-believed complication of renal transplantation. Transplant Proc. 1979; 11(2): 1280-1[PubMed]
  • 23. Silva DS, Andrade Edos S, Elias RM, David-Neto E, Nahas WC, Castro MC, et al. The perception of sleep quality in kidney transplant patients during the first year of transplantation. Clinics (Sao Paulo). 2012; 67(12): 1365-71[DOI][PubMed]
  • 24. Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant. 2011; 25(1)-21[DOI][PubMed]
  • 25. Kovacs AZ, Molnar MZ, Szeifert L, Ambrus C, Molnar-Varga M, Szentkiralyi A, et al. Sleep disorders, depressive symptoms and health-related quality of life--a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant. 2011; 26(3): 1058-65[DOI][PubMed]
  • 26. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int. 2005; 18(6): 643-50[DOI][PubMed]
  • 27. Pescovitz MD, Navarro MT. Immunosuppressive therapy and post-transplantation diarrhea. Clin Transplant. 2001; 15 Suppl 4: 23-8[DOI][PubMed]
  • 28. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001; 44(6): 932-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments